I-Mab (IMAB)
NASDAQ: IMAB · IEX Real-Time Price · USD
1.800
-0.010 (-0.55%)
Apr 26, 2024, 4:30 PM EDT - Market closed

I-Mab Revenue

In the year 2023, I-Mab had annual revenue of $3.90M, a decrease of -112.27%.

Revenue (ttm)
$3.90M
Revenue Growth
-112.27%
P/S Ratio
38.31
Revenue / Employee
$10,315
Employees
378
Market Cap
149.38M USD

Revenue Chart

* The company reports in CNY currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20233.90M35.69M-112.27%
Dec 31, 2022-31.79M-45.54M-331.12%
Dec 31, 202113.75M-222.13M-94.17%
Dec 31, 2020235.88M231.60M5,403.91%
Dec 31, 20194.29M-3.50M-44.94%
Dec 31, 20187.78M6.04M345.57%
Dec 31, 20171.75M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
High Tide 497.66M
American Well 259.05M
Quipt Home Medical 185.18M
Biodesix 49.09M
Scilex Holding Company 46.74M
ClearPoint Neuro 23.96M
MSP Recovery 7.71M
Revenue Rankings